Cellosaurus logo
expasy logo

Cellosaurus MEL-CLS-1 (CVCL_5619)

[Text version]
Cell line name MEL-CLS-1
Synonyms FO-1; FO #1; FO 1
Accession CVCL_5619
Resource Identification Initiative To cite this cell line use: MEL-CLS-1 (RRID:CVCL_5619)
Comments Population: Caucasian.
Characteristics: Established from a xenograft (CLS=300175).
Doubling time: 38 hours (Note=At 49th passage) (PubMed=994214).
Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
Sequence variations
  • Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300175).
Disease Amelanotic melanoma (NCIt: C3802)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_GZ38 (FO1-12)
Sex of cell Female
Age at sampling 54Y
Category Cancer cell line
STR profile Source(s): CLS=300175

Markers:
AmelogeninX
CSF1PO10,12
D3S135815,18
D5S81812,13
D7S8209,11
D8S117912,14
D13S31712
D16S5399,12
D18S5117
D21S1127
FGA19,23
Penta D9
Penta E14,17
TH019
TPOX8
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=994214; DOI=10.1093/jnci/56.6.1131
Beppino Carlo Giovanella, John Sebastian Stehlin Jr., C. Santamaria, Sun Ock Yim, Alton C. Morgan Jr., Leo J. Williams Jr., Albert Leibovitz, Philip J. Fialkow, David Meday Mumford;
Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.
J. Natl. Cancer Inst. 56:1131-1142(1976)

PubMed=327080; DOI=10.1093/jnci/59.1.221
Jorgen Fogh, Jens M. Fogh, Thomas Orfeo;
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
J. Natl. Cancer Inst. 59:221-226(1977)

PubMed=833871; DOI=10.1093/jnci/58.2.209
Jorgen Fogh, William C. Wright, James D. Loveless;
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

PubMed=3518877; DOI=10.3109/07357908609038260
Jorgen Fogh;
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=2624919; DOI=10.1007/BF01744892; PMCID=PMC11038635
Ludovico Guarini, Massimo Temponi, Gretchen M. Edwalds, Joseph R. Vita, Paul B. Fisher, Soldano Ferrone;
In vitro differentiation and antigenic changes in human melanoma cell lines.
Cancer Immunol. Immunother. 30:262-268(1989)

PubMed=1898655; DOI=10.1172/JCI114984; PMCID=PMC295046
Claudio M. D'Urso, Zhi-Gang Wang, Yan Cao, Revati J. Tatake, Richard A. Zeff, Soldano Ferrone;
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
J. Clin. Invest. 87:284-292(1991)

PubMed=8537970; DOI=10.1093/jnci/88.2.100; PMCID=PMC2248456
Nicholas P. Restifo, Francesco M. Marincola, Yutaka Kawakami, Jeffery Karl Taubenberger, John R. Yannelli, Steven A. Rosenberg;
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
J. Natl. Cancer Inst. 88:100-108(1996)

PubMed=15661905; DOI=10.4049/jimmunol.174.3.1462; PMCID=PMC2245899
Chien-Chung Chang, Michael Campoli, Nicholas P. Restifo, Xin-Hui Wang, Soldano Ferrone;
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
J. Immunol. 174:1462-1471(2005)

Cross-references
Cell line collections (Providers) CLS; 300175
Cell line databases/resources cancercelllines; CVCL_5619
Anatomy/cell type resources BTO; BTO_0002943
Encyclopedic resources Wikidata; Q54905083
Entry history
Entry creation04-Apr-2012
Last entry update19-Dec-2024
Version number23